0.6728
price down icon3.56%   -0.0248
pre-market  시장 영업 전:  .69   0.0172   +2.56%
loading

Neumora Therapeutics Inc (NMRA) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
47.31%
60.07
114.00 56.86 - -
Operating Income/Loss
47.31%
-60.07
-114.00 -56.86 - -
Nonoperating Income/Loss
14.63%
6.353
5.542 3.837 - -
Income/Loss From Continuing Operations Before Tax
50.47%
-53.72
-108.46 -53.03 -38.54 -35.62
Income/Loss From Continuing Operations After Tax
50.59%
-53.72
-108.73 -53.03 -38.54 -35.62
Net Income/Loss
50.59%
-53.72
-108.73 -53.03 -38.54 -35.62
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
433.72%
157.94
29.59 46.69 - -
Diluted Average Shares
433.72%
157.94
29.59 46.69 - -
Basic Earnings Per Share
750.00%
-0.34
-0.04 -1.14 - -
Diluted Earnings Per Share
750.00%
-0.34
-0.04 -1.14 - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.42
price down icon 5.24%
$67.87
price down icon 6.49%
$32.11
price down icon 2.70%
$24.20
price down icon 13.63%
$94.74
price down icon 6.29%
biotechnology ONC
$241.75
price down icon 4.88%
자본화:     |  볼륨(24시간):